Latest filing published 03 Mar 2026 for AbbVie Inc., €2.9M.
All filings by Perry C. Siatis on record concern AbbVie Inc. We count 51 filings; the first trade dates from 16 February 2023 and the latest from 2 March 2026.
On the market, this insider has only sold: 18 sales, €22.0M in total. Other entries cover 21 share grants and 11 option exercises. Since January 2026: no purchases and 4 sales on the market.
The record was last updated on 3 March 2026 with an open-market sale (€2.1M) in AbbVie Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 27 declarations